Ajanta Pharma informs about updates

12 Sep 2022 Evaluate

Ajanta Pharma has informed that its formulation facility at Dahej was inspected by US FDA from 5th September 2022 to 9th September 2022. At the end of the inspection, Form 483 was issued to them with 2 procedural observations. The company is in the process of responding to the same within the stipulated time prescribed by US FDA.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2800.40 -103.80 (-3.57%)
23-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1756.35
Dr. Reddys Lab 1252.55
Cipla 1222.70
Zydus Lifesciences 860.55
Lupin 2297.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×